US FDA places partial clinical hold on Gilead’s studies on Magrolimab for AML treatment
The FDA action follows the previously announced discontinuation of the Phase 3 ENHANCE study of magrolimab in higher-risk…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Acute Myeloid Leukemia
Piramal collaborates with BerGenBio to develop leukemia treatment
The collaboration will be focused on the development of bemcentinib for the treatment of elderly patients with relapsed Acute…
AML market to surpass $1.5 bn by 2026
The acute myeloid leukemia (AML) market across the seven major countries (7MM) of the US, France, Germany, Italy, Spain, the UK,…